Merus
Utrecht
About Merus
Merus is a biotechnology company that discovers and develops new treatments for cancer patients. The company utilizes its proprietary Multiclonics Platform technology to advance its clinical pipeline of medicines. Merus conducts scientific research and clinical trials focused on developing novel treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $1.4B
- Funding stage: M&A
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: nasdaq:MRUS
- Website: merus.nl
- Phone: +31 30 253 8800
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/merus-79139 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.